Basit öğe kaydını göster

dc.contributor.authorTopçu, Elif Göknur
dc.contributor.authorÜlker, Volkan
dc.contributor.authorGündüz, Nermin
dc.contributor.authorGöksever Çelik, Hale
dc.date.accessioned2022-01-17T07:56:22Z
dc.date.available2022-01-17T07:56:22Z
dc.date.issued2021en_US
dc.identifier.citationTopçu, E. G., Ülker, V., Gündüz, N. ve Göksever Çelik, H. (2021). Is there any possibility of uterine sarcoma, STUMP and benign myoma variants in the patients operated for myoma uteri. Journal of Experimental and Clinical Medicine (Turkey), 38(4), 538-544. https://doi.org/10.52142/omujecm.38.4.26en_US
dc.identifier.issn1309-4483
dc.identifier.urihttps://doi.org/10.52142/omujecm.38.4.26
dc.identifier.urihttps://hdl.handle.net/20.500.12511/8824
dc.description.abstractMalignant pathologies may be observed in the histopathological examination of the patients who were operated with the diagnosis of myoma uteri. We aimed to investigate the rates of detection of uterine sarcoma, smooth muscle tumor of uncertain malignant potential and benign myoma variants who were operated due to myoma uteri. Patients who were operated with the diagnosis of myoma uteri between 2012-2018 were included. Patients with and without malignant pathology were compared in terms of their characteristics. The malignancy was encountered in 39 patients (1.5%) among 2583 patients. A significant difference was found between the patients with and without malignancy in terms of age, admission complaints, and cervical smear results. Patients in the malignant group were found to be older (52.5±11.0 vs 48.1±6.1, p=0.016). Postmenopausal bleeding was significantly a more common complaint in the malignant group (p=0.028). The rate of abnormal cytology in the cervical smear results in the malignant group was 5.1% (p=0.004). Pathology reports of the patients who were operated for myoma uteri may result with malignancy. In the preoperative evaluation, it is necessary to pay attention to the patients' characteristics, to evaluate the risk factors for the possibility of a malignancy. © 2021 Ondokuz Mayis Universitesi.en_US
dc.language.isoengen_US
dc.publisherOndokuz Mayıs Universityen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectHysterectomyen_US
dc.subjectMyoma Uterien_US
dc.subjectMyomectomyen_US
dc.subjectSTUMPen_US
dc.subjectUterine Sarcomaen_US
dc.titleIs there any possibility of uterine sarcoma, STUMP and benign myoma variants in the patients operated for myoma uterien_US
dc.typearticleen_US
dc.relation.ispartofJournal of Experimental and Clinical Medicine (Turkey)en_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Kadın Hastalıkları ve Doğum Ana Bilim Dalıen_US
dc.authorid0000-0002-8912-8160en_US
dc.identifier.volume38en_US
dc.identifier.issue4en_US
dc.identifier.startpage538en_US
dc.identifier.endpage544en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.52142/omujecm.38.4.26en_US
dc.identifier.scopusqualityQ4en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster